Author

Wolfgang Uter

EFFECTIVENESS, IMMUNOGENICITY, SAFETY AND PHARMACOECONOMIC ASPECTS FOLLOWING A SWITCH FROM REFERENCE INFLIXIMAB TO THE BIOSIMILAR SB2 IN INFLAMMATORY BOWEL DISEASE PATIENTS: A 6 MONTHS PROSPECTIVE COHORT STUDY

Sarah Fischer, Entcho Klenske, Heike Schmitt, Francesco Vitali, Simon Hirschmann, Franz Koch, Andreas Ramming, Sebastian Zundler, Sabine Krebs, Frank Dörje, Daniel Nagore, Sebastian Meyer, Wolfgang Uter, Markus F. Neurath, Raja Atreya

IN VIVO MOLECULAR IMAGING USING FLUORESCENT ANTI-TNF ANTIBODIES AND CONFOCAL LASER ENDOMICROSCOPY PREDICTS RESPONSE TO ANTI-TNF THERAPY IN CROHN'S DISEASE

Raja Atreya, Helmut Neumann, Clemens Neufert, Maximilian J. Waldner, Ulrike Billmeier, Yurdagül Zopf, Marcus Willma, Christine App, Tino Münster, Hermann Kessler, Stefanie Maas, Bernd Gebhardt, Ralph Heimke-Brinck, Eva Reuter, Frank Doerje, Wolfgang Uter, Thomas D. Wang, Ralf Kiesslich, Michael Vieth, Ewald Hannappel, T

Item 1 - 2 / 2
1